Acutus Medical Statistics
Total Valuation
Acutus Medical has a market cap or net worth of $1.75 million. The enterprise value is $20.27 million.
Market Cap | 1.75M |
Enterprise Value | 20.27M |
Important Dates
The next estimated earnings date is Tuesday, May 21, 2024, after market close.
Earnings Date | May 21, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Acutus Medical has 29.72 million shares outstanding. The number of shares has increased by 3.23% in one year.
Shares Outstanding | 29.72M |
Shares Change (YoY) | +3.23% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 3.16% |
Owned by Institutions (%) | 23.30% |
Float | 23.42M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.26 |
Forward PS | 0.07 |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 3.06 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.48
Current Ratio | 3.48 |
Quick Ratio | 2.81 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -0.12 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -160.72% |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | $28,783 |
Profits Per Employee | -$291,165 |
Employee Count | 230 |
Asset Turnover | 0.06 |
Inventory Turnover | 0.69 |
Taxes
In the past 12 months, Acutus Medical has paid $1.45 million in taxes.
Income Tax | 1.45M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -93.14% in the last 52 weeks. The beta is 0.26, so Acutus Medical's price volatility has been lower than the market average.
Beta (1Y) | 0.26 |
52-Week Price Change | -93.14% |
50-Day Moving Average | 0.15 |
200-Day Moving Average | 0.33 |
Relative Strength Index (RSI) | 31.72 |
Average Volume (30 Days) | 1,216,101 |
Short Selling Information
The latest short interest is 553,603, so 1.86% of the outstanding shares have been sold short.
Short Interest | 553,603 |
Short Previous Month | 845,166 |
Short % of Shares Out | 1.86% |
Short % of Float | 2.36% |
Short Ratio (days to cover) | 0.68 |
Income Statement
In the last 12 months, Acutus Medical had revenue of $6.62 million and -$66.97 million in losses. Loss per share was -$0.87.
Revenue | 6.62M |
Gross Profit | -547,000 |
Operating Income | 5.00M |
Pretax Income | 2.40M |
Net Income | -66.97M |
EBITDA | -819,000 |
EBIT | -446,000 |
Loss Per Share | -$0.87 |
Balance Sheet
The company has $19.95 million in cash and $38.47 million in debt, giving a net cash position of -$18.51 million or -$0.62 per share.
Cash & Cash Equivalents | 19.95M |
Total Debt | 38.47M |
Net Cash | -18.51M |
Net Cash Per Share | -$0.62 |
Equity / Book Value | -4.02M |
Book Value Per Share | -0.14 |
Working Capital | 24.53M |
Cash Flow
In the last 12 months, operating cash flow was -$63.53 million and capital expenditures -$92,000, giving a free cash flow of -$63.62 million.
Operating Cash Flow | -63.53M |
Capital Expenditures | -92,000 |
Free Cash Flow | -63.62M |
FCF Per Share | -$2.14 |
Margins
Gross margin is -8.26%, with operating and profit margins of 75.59% and -1,011.60%.
Gross Margin | -8.26% |
Operating Margin | 75.59% |
Pretax Margin | 36.28% |
Profit Margin | -1,011.60% |
EBITDA Margin | -12.37% |
EBIT Margin | -6.74% |
FCF Margin | -961.09% |
Dividends & Yields
Acutus Medical does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -3.23% |
Shareholder Yield | -3.23% |
Earnings Yield | -3,818.95% |
FCF Yield | -3,628.26% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Acutus Medical has an Altman Z-Score of -19.36 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -19.36 |
Piotroski F-Score | 3 |